THREAD: During this pandemic, treatment providers and governments have faced shortages of #COVID19 drugs, test reagents, masks, and ventilator valves caused by corporations controlling supply using patents, trade secrets or other IP.
We compiled examples of such shortages
We compiled examples of such shortages

Example 1- Impact of intellectual property barriers on #COVID19 drugs.
#COVIDshortages
#WhyWeNeedIPWaiver
#COVIDshortages
#WhyWeNeedIPWaiver
Example 2- Impact of intellectual property barriers on future #COVID19 #vaccines.
#COVIDshortages
#WhyWeNeedIPWaiver
#COVIDshortages
#WhyWeNeedIPWaiver
Example 3- Impact of intellectual property barriers on #COVID19 tests.
#COVIDshortages
#WhyWeNeedIPWaiver
#COVIDshortages
#WhyWeNeedIPWaiver
Example 4 - Impact of intellectual property barriers on #COVID19 ventilator valves.
#COVIDshortages
#WhyWeNeedIPWaiver
#COVIDshortages
#WhyWeNeedIPWaiver
Example 5 - Impact of intellectual property barriers on #COVID19 N95 respirators (masks).
#COVIDshortages
#WhyWeNeedIPWaiver
#COVIDshortages
#WhyWeNeedIPWaiver
Example 6- Impact of intellectual property barriers on #COVID19 testing kit reagents.
#COVIDshortages
#WhyWeNeedIPWaiver
#COVIDshortages
#WhyWeNeedIPWaiver
If the waiver proposal by
is approved by @WTO, it will support uninterrupted scale-up of production and supply of medical tools to collectively address the global challenge facing all countries.
Read more
#WhyWeNeedIPWaiver https://bit.ly/3nLAzCC


Read more
